CompletedPhase 3NCT00226044

Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

Studying Esophageal atresia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rijnstate Hospital
Principal Investigator
S.N. de Wildt, Prof. Dr.
Erasmus Medical Center
Intervention
Omeprazole rectally 1mg/kg(drug)
Enrollment
17 enrolled
Eligibility
All sexes
Timeline
2005 – 2017

Study locations (1)

Collaborators

Erasmus Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00226044 on ClinicalTrials.gov

Other trials for Esophageal atresia

Additional recruiting or active studies for the same condition.

See all trials for Esophageal atresia →

← Back to all trials